Mount Sinai Innovation Partners
@MountSinai_IP
We facilitate the real-world application and commercialization of @MountSinaiNYC and @IcahnMountSinai discoveries and the development of research partnerships
03-06-2013 15:18:00
2,8K Tweet
1,3K Takipçi
340 Takip Edilen
Mark Lebwohl, MD, Dean for Clinical Therapeutics Icahn School of Medicine at Mount Sinai, shares an overview of his research investigating the use of bimekizumab treatment for hepatic adverse events among patients with moderate to severe psoriasis.
Learn more Healio: healio.com/news/dermatolo…